• SB-505124 Hydrochloride: Selective ALK Inhibitor for TGF-β P

  2026-06-16

  SB-505124 hydrochloride is a highly selective, reversible ATP-competitive inhibitor that targets ALK4, ALK5, and ALK7, enabling precise modulation of TGF-β/activin signaling. The compound shows potent inhibition of Smad2/3 phosphorylation without cytotoxicity in A498 renal epithelial cells up to 100 μM. Its solubility profile and validated efficacy in fibrosis and glaucoma models make it a robust research tool for dissecting fibroblast activation and differentiation.

• Biomimetic mRNA Nanovaccines Target Neutrophils in Liver Can

  2026-06-16

  This study pioneers a biomimetic mRNA nanovaccine (CMNPs) that specifically targets and reprograms tumor-associated neutrophils via CD300LD-coated liposomes and IL-36γ mRNA to enhance anti-tumor immunity in hepatocellular carcinoma. The approach demonstrates substantial tumor growth inhibition and improved survival, providing a new avenue for neutrophil-directed cancer immunotherapy.

• Direct Enzymatic Synthesis of Fatty Amines from Trilaurin: A

  2026-06-15

  The reference study introduces a direct biocatalytic method to convert renewable triglycerides, such as Trilaurin (Glycerol Tridodecanoate), into primary fatty amines using an enzymatic cascade. This approach bypasses traditional harsh chemical routes, achieving high selectivity and yield under mild conditions, with important implications for sustainable synthesis in industrial chemistry.

• BAPTA Calcium Chelator: Advanced Workflows for Apoptosis Res

  2026-06-15

  BAPTA enables precise, reproducible modulation of intracellular calcium, making it indispensable for dissecting apoptosis and cell signaling in toxicology and cell biology. APExBIO's high-purity calcium chelator streamlines advanced experimental workflows and troubleshooting for studies targeting the IP3R/Ca2+/STAT3 axis.

• Precision Neutrophil Isolation: Unlocking Functional Mouse I

  2026-06-14

  Explore how the Mouse Neutrophil Cell Isolation Kit enables high-purity, activation-free neutrophil isolation from mouse tissues. This article uniquely examines the link between isolation fidelity and advanced mRNA nanovaccine research, offering actionable protocol guidance and deeper translational insights.

• Alternariol-Induced Stellate Cell Activation Fuels Liver Fib

  2026-06-13

  A recent omics-driven study demonstrates that Alternariol (AOH), a prevalent foodborne mycotoxin, directly induces hepatic stellate cell transdifferentiation, promoting liver fibrosis through NF-κB, ferroptosis, and autophagy pathways. These insights clarify AOH’s hepatotoxicity and introduce CotA laccase-mediated detoxification as a prospective intervention.

• Lamotrigine in Research: Sodium Channel Blockade & 5-HT Inhi

  2026-06-12

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, empowers reproducible in vitro workflows for epilepsy and neurocardiac research. Explore robust assay setups, protocol enhancements, and troubleshooting strategies that maximize data integrity and uncover translational insights.

• M344 HDAC Inhibition Suppresses Neuroblastoma Growth In Vivo

  2026-06-12

  The referenced study establishes M344 as a potent histone deacetylase inhibitor that effectively suppresses neuroblastoma tumor growth by inducing cell cycle arrest and apoptosis. These findings highlight M344's potential to improve neuroblastoma therapy protocols and reduce toxicity compared to current HDAC inhibitors.

• Forskolin as an Adenylate Cyclase Activator: Experimental Po

  2026-06-11

  Forskolin enables precise modulation of cAMP signaling, transforming workflows in inflammation, stem cell, and neuroendocrine research. This guide delivers practical protocols, troubleshooting insights, and evidence-backed strategies to maximize reproducibility and impact using APExBIO's benchmark adenylate cyclase activator.

• Bafilomycin C1: Strategic V-ATPase Inhibition in High-Conten

  2026-06-11

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, empowers next-generation high-content phenotypic screens and early-stage drug de-risking. This article reveals advanced assay strategies and translational opportunities not covered in standard protocols.

• Ac-YVAD-CMK: Advancing Pyroptosis Inhibition in Translationa

  2026-06-10

  This article explores how Ac-YVAD-CMK (N-Ac-Tyr-Val-Ala-Asp-CMK) empowers translational researchers to dissect inflammasome-driven pathways, focusing on the mechanistic control of inflammatory cytokine release and pyroptosis. By integrating the latest insights from TMEM16F-related liver immunology and evidence-based guidance, we provide a strategic roadmap for deploying this selective caspase-1 inhibitor in next-generation inflammation models.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-06-10

  Harnessing the high-purity MTT assay reagent from APExBIO empowers researchers to quantify cell metabolic activity and viability with confidence, even in complex disease models like kidney fibrosis. This article delivers protocol clarity, optimization strategies, and troubleshooting insights for robust, reproducible in vitro cell proliferation and cytotoxicity workflows.

• Triacetin in Bauhinia divaricata: Antiadipogenic Mechanisms

  2026-06-09

  The recent study on Bauhinia divaricata L. sheds light on its potent antiadipogenic effects in adipocyte cell models, with triacetin identified as a major active component. These findings provide a foundation for targeted research into natural and synthetic triglyceride compounds for metabolic regulation and anti-obesity strategies.

• Cimetidine: H2 Receptor Antagonist for Cancer & BBB Research

  2026-06-09

  Cimetidine, a histamine-2 receptor antagonist from APExBIO, offers a distinct partial agonist profile and high solubility, making it a robust tool for cancer and blood-brain barrier (BBB) research. Its unique pharmacological actions support mechanistic studies and workflow reproducibility, particularly in gastrointestinal cancer research.

• Biotin-HPDP in Thiol-Specific Protein Labeling: Protocols &

  2026-06-08

  Biotin-HPDP empowers scientists with highly selective, reversible thiol-specific protein labeling for advanced redox and neurodegeneration research. Discover optimized protocols, troubleshooting strategies, and the latest translational applications informed by cutting-edge studies and real-world workflows.

445 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page